8-K: Predictive Oncology Pivots to Digital Asset Treasury

Predictive Oncology Inc. is undergoing a significant strategic shift, raising $200 million in a private placement to establish a digital asset treasury focused on Aethir tokens (ATH) and appointing new leadership.

Summary

• Predictive Oncology Inc. (POAI) entered into private placement agreements on September 29, 2025, to raise $200 million.
• The capital raise consists of a $100 million cash offering and a $100 million in-kind cryptocurrency offering, primarily Aethir tokens (ATH).
• The cash offering includes approximately 55.2 million shares of common stock and 11.5 million pre-funded warrants, both at a purchase price of $0.7751 per share (pre-split basis).
• The cryptocurrency offering involves pre-funded warrants to purchase approximately 223.6 million shares, with consideration primarily in ATH tokens.
• The company is launching a digital asset treasury strategy, with net cash proceeds from the private placements to be used to purchase additional ATH tokens.
• The digital asset strategy will be overseen by a special Board committee and a new Chief Investment Officer, Thomas McLaughlin, who will report to this committee.
• DNA Holdings Venture, Inc. (DNA), an investor in the cash offering, will serve as a strategic advisor and asset manager for the digital asset treasury.
• DNA will receive warrants to purchase approximately 20.3 million shares at an exercise price of $0.7751 per share as compensation.
• A one-for-fifteen (1-for-15) reverse stock split of the company's common stock will become effective at 12:01 a.m. on September 30, 2025.
• Nancy Chung-Welch, Ph.D. resigned from the Board of Directors, and Shawn Matthews was appointed to the Board, effective upon the closing of the private placements.
• The company's bylaws were amended to limit the Board of Directors to a maximum of seven directors, effective September 26, 2025.
• The closing of the private placements is expected on or about October 2, 2025.

Sentiment

Score: 6

Explanation: The filing indicates a bold strategic pivot with significant capital infusion and a clear plan for digital asset management, which could be transformative. However, the inherent volatility and regulatory uncertainty of the cryptocurrency market, coupled with substantial shareholder dilution and the contingency of shareholder approval for a large portion of the warrants, introduce considerable risks. The positive aspects are balanced by these significant uncertainties and potential downsides.

Positives

• Secured $200 million in capital, providing significant funding for the new digital asset treasury strategy.
• Strategic pivot into the high-growth AI infrastructure sector through Aethir, a leading decentralized GPU network.
• Partnership with DNA Holdings Venture, Inc. brings specialized expertise in digital asset strategies and asset management.
• The 'Structural Alpha' component of the transaction, including discounted token acquisition and a foundation-led buyback program, could enhance returns.
• Appointment of a new Chief Investment Officer and a dedicated Board subcommittee indicates a structured approach to managing digital assets.

Negatives

• Significant shareholder dilution is expected due to the issuance of a large number of shares and warrants in the private placements.
• The new digital asset strategy exposes the company to the highly volatile and uncertain cryptocurrency market.
• Exercise of cryptocurrency pre-funded warrants is contingent on shareholder approval, introducing a potential delay or failure point.
• The company's historical financial statements do not reflect the potential variability in earnings from digital asset holdings, making future performance difficult to evaluate.
• The concentration of ATH holdings limits diversification and amplifies risks associated with that specific digital asset.

Risks

• The price of Aethir tokens (ATH) and other digital assets is highly volatile, leading to potential significant fluctuations in operating results and share price.
• Uncertainty in successfully implementing the new digital asset treasury strategy and achieving anticipated scale or profitability.
• Operational risks associated with ATH treasury strategy, including staking, liquid staking, enterprise compute sales, and decentralized finance activities, due to rapid ecosystem evolution, protocol changes, and reliance on third-party service providers.
• Concentration of ATH holdings limits risk mitigation and enhances the impact of ATH price declines on financial condition.
• Disruption or unanticipated difficulties in the Aethir network could negatively impact ATH value and the company's ability to transfer or sell ATH.
• Significant legal, commercial, regulatory, and technical uncertainty surrounding ATH and other digital assets, potentially affecting their price and the ability to operate blockchain-based applications.
• Evolving regulatory environment may require registration as a money services business or money transmitter, leading to increased compliance costs or operational shutdowns.
• Classification of digital assets as securities could subject the company to extensive regulation, significant costs, or force cessation of operations, including potential registration as an investment company.
• The company is not subject to legal and regulatory protections applicable to investment companies or commodity pools, leaving shareholders without certain safeguards.
• Digital asset trading venues carry greater risks of fraud, market manipulation, security failures, and operational problems compared to established asset classes, potentially affecting digital asset values.
• Digital asset holdings are less liquid than cash and cash equivalents and may not serve as a reliable source of liquidity during market instability.
• The availability of spot exchange-traded products (ETPs) for digital assets may adversely affect the market price of the company's listed securities by offering alternative investment exposure.
• Digital asset lending and decentralized finance (DeFi) arrangements expose the company to risks of borrower default, smart contract bugs, liquidation, governance attacks, and cybersecurity threats.
• Reliance on open-source code by digital asset networks exposes the company to risks from competitive networks, maintenance failures, and security vulnerabilities.
• Lack of legal recourse and insurance for digital assets increases the risk of total loss in the event of theft or destruction.
• Custody risks, including security breaches, loss of private keys, and custodian insolvency, could lead to loss of digital assets.
• Irreversibility of digital asset transactions exposes the company to risks of theft, loss, and human error.
• Significant competition in the digital asset industry from other companies with similar strategies, including those with substantial ATH holdings.
• Aethir is subject to technological obsolescence, including competition from emerging blockchain and artificial intelligence protocols.
• Changes in tax regulation or policy regarding staking rewards for ATH could lead to additional tax liability.
• A cyberattack or other malicious attack on the Aethir network could materially impact the value of ATH.
• The emergence or growth of other digital assets, including government-backed CBDCs and stablecoins, could negatively impact ATH price.
• Loss of key personnel or the Asset Manager (DNA Holdings Venture, Inc.) could impair the ability to operate and manage the digital asset treasury strategy.
• Stockholders will experience significant dilution from the PIPE and substantial dilution if pre-funded warrants are exercised.
• The company may become obligated to pay liquidated damages if it fails to file, obtain effectiveness of, or maintain effectiveness of the resale registration statement.

Future Outlook

The company intends to continue its current lines of business in addition to pursuing its digital asset treasury strategy. The predominant business activity is expected to be the digital asset treasury strategy, focused on the ATH token. The company plans to acquire additional ATH in the open market and earn yield through staking and other activities. A special committee of the Board and a new Chief Investment Officer will oversee this strategy, implemented by DNA Holdings Venture, Inc. The company will use commercially reasonable efforts to file resale registration statements and maintain listing on its Trading Market. Shareholder approval is required for the exercise of cryptocurrency pre-funded warrants, with the company committed to seeking this approval promptly and repeatedly if necessary.

Management Comments

• The company intends to use the net cash proceeds from the Private Placements primarily to purchase ATH, which, together with the contribution of the ATH from investors in the Cryptocurrency Offering, will establish the company's cryptocurrency treasury, as well as provide for working capital and general corporate purposes, and for the payment of transaction costs incurred in respect of the Private Placements.
• The company intends to continue to pursue its current lines of business in addition to the pursuit of its digital asset treasury strategy.

Industry Context

This announcement marks a significant pivot for Predictive Oncology Inc. into the burgeoning digital asset and AI infrastructure sectors. By focusing on Aethir (ATH), a decentralized GPU network, the company is positioning itself to capitalize on the increasing demand for compute power driven by artificial intelligence. This move aligns with a broader trend of companies exploring digital assets for treasury management and strategic investments, seeking to leverage the growth potential of blockchain-based infrastructure (DePIN). The company's strategy to generate yield through staking and other DeFi activities reflects a sophisticated approach to digital asset management, aiming to create a non-correlated conversion channel for its assets, which could offer a unique hedge against market volatility compared to traditional digital asset holding companies.

Comparison to Industry Standards

• Aethir's reported $150M+ in on-chain Annual Recurring Revenue (ARR) positions it as a market leader in the DePIN space, significantly outperforming competitors like io.net (5x larger) and Akash (26x larger).
• Aethir's pricing for high-performance NVIDIA H100 GPUs at $1.25 per hour is highly competitive, being 50% cheaper than Lambda Labs ($2.49/hr) and 80% cheaper than hyperscalers like AWS ($6.04/hr), Azure ($4.70/hr), and Google Cloud ($2.93/hr).
• The network's scale, with 430,000+ GPU containers and over 5,000 NVIDIA H100s, H200s, and B200s across 200+ locations in 90+ countries, is unrivaled in the decentralized GPU market, surpassing competitors largely focused on US/Europe.
• The company's strategy to redeem ATH for GPU compute time and then sell that compute for cash provides an inherent hedge against the 'death spiral' seen in other digital asset treasuries, offering a non-correlated conversion channel that allows realization of full cash value without direct market sales of ATH, a distinct advantage over typical crypto-holding entities.

Management Changes

Corporate Governance

Related Party Transactions

• DNA Holdings Venture, Inc. (DNA) is an investor in the Cash Offering, and also serves as the Strategic Advisor and Asset Manager for the company's digital asset treasury.
• DNA will receive Strategic Advisor Warrants to purchase approximately 20.3 million shares of common stock as compensation for its services.
• DNA, as Asset Manager, will receive an asset-based management fee of 1.00% per annum of Account Assets and an incentive fee of 25% of profits earned on Account Assets in excess of 7%.
• A Side Letter agreement was entered into with DCI Foundation, a Panama foundation company and developer of the Aethir network. DCI Foundation is responsible for any deficiencies related to 'Locked Crypto' contributed by purchasers and will deliver an additional 20% of ATH tokens purchased by the company on the open market.

Stakeholder Impact

• **Shareholders**: Will experience significant dilution from the private placements and potential further dilution upon warrant exercise. The strategic pivot introduces high-risk, high-reward exposure to the volatile digital asset market. Shareholder approval is required for a significant portion of the warrants.
• **Employees**: The strategic shift requires specialized skillsets and operational infrastructure, potentially leading to new hiring in digital asset management and technology, but also a shift in focus from the existing AI-driven drug development business.
• **Customers**: The company intends to continue its AI-driven drug development business, so existing customers should not be immediately impacted, but the primary focus will shift to the digital asset strategy.
• **Suppliers**: No direct impact mentioned, but the shift in business focus may alter future procurement needs.
• **Creditors**: The capital raise strengthens the company's balance sheet, but the high volatility and regulatory uncertainty of digital assets could introduce new risks to the company's financial stability.

Next Steps

• Closing of the Private Placements, expected on or about October 2, 2025.
• Appointment of Thomas McLaughlin as Chief Investment Officer at or prior to the Closing Date.
• Adoption of a Treasury Reserve Policy, with ATH as the primary treasury reserve asset.
• Filing of a resale registration statement with the SEC no later than the 15th calendar day following the Closing Date.
• Company to use best efforts to cause the resale registration statements to be declared effective promptly.
• Company to hold a special meeting of shareholders to obtain approval for the exercise of Cryptocurrency Pre-Funded Warrants, at the earliest practical date, but no later than December 5, 2025.
• If shareholder approval is not obtained, the company will call a meeting every four months thereafter until approval is obtained.
• Company to use net cash proceeds from private placements to purchase additional ATH tokens.
• DNA Holdings Venture, Inc. to implement the digital asset treasury strategy and provide asset management services.

Key Dates

Recommendation

The company is undergoing a radical strategic pivot into the highly speculative and volatile digital asset space, specifically Aethir tokens. While the capital raise provides significant funding and the partnership with DNA Holdings Venture, Inc. brings expertise, the inherent risks of cryptocurrency, regulatory uncertainty, and substantial shareholder dilution are considerable. The success of this new strategy is unproven, and the company's historical business is being de-emphasized. Given the high risk and speculative nature of this new direction, a 'hold' recommendation is appropriate for existing investors to observe the execution of this strategy and the market's reaction. New investors should approach with extreme caution due to the significant uncertainties and potential for substantial losses, despite the potential for high returns if the strategy is successful.

Keywords

Predictive Oncology, POAI, Digital Asset Treasury, Aethir, ATH Token, Cryptocurrency, Private Placement, GPU Network, DePIN, Warrants, Reverse Stock Split, Corporate Governance, Strategic Shift, Blockchain, AI Infrastructure